Never say never ( possible exit catalysts). Anything material and sensitive to share price, don't think the company can share without making public announcement. So it's either you wait with your pants up or down, things can go different direction too. The company is just listed for 3 years and most of their portfolio companies aren't really into mass commercialising stage, except for ostomy bag which is underway, which could need a little bit of patience, last check it's product updated patent date is in June 2018. Unless anyone familiar with B Braun could give us an update on the launch, there is nothing for us to do except to wait. Although the dividend might not be significant, the company could see improvement in it's cash flow which I think is a turning point for its business model. But whether this would make a great company to own, we will only know in a few years' time.
Reply to @ozxinvest : I don't remember if it Oct or Dec, but Trendlines CEO did say they will have a meeting with B Braun and see whether they can disclose more
I have never really like their biz model. Market has also all along under appreciate their biz. Even if one exits next year, I will think it will also under perform the general market. its a lose lose situation.
Reply to @learningboy1988 : Haha... not big enough yet.